EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of Human Milk Oligosaccharide 2′-Fucosyllactose Ingestion on Weight Loss and Markers of Health

Joungbo Ko, Choongsung Yoo, Dante Xing, Jisun Chun, Drew E Gonzalez iD, Broderick L Dickerson iD, Megan Leonard iD, Victoria Jenkins iD, Marie van der Merwe iD, Carolyn M Slupsky iD, Ryan Sowinski iD, Christopher J Rasmussen und 1 weitere

Nutrients · 2024

DOI: 10.3390/nu16193387 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Joungbo Ko und 12 weiteren Autor:innen. Beteiligte Einrichtung: Exercise & Sport Nutrition Lab, Department of Kinesiology and Sports Management, Texas A&M University, College Station, TX 77843, USA. Hauptthemen laut MEDLINE: Trisaccharides, Milk, Human, Biomarkers, Weight Loss. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Advanced Protein Technologies Corp.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

2′-Fucosyllactose (2′-FL) is an oligosaccharide contained in human milk and possesses prebiotic and anti-inflammatory effects, which may alleviate skeletal muscle atrophy under caloric restriction. This study evaluated the impacts of 12 weeks of 2′-FL supplementation in conjunction with exercise (10,000 steps/day, 5 days/week) and energy-reduced (−300 kcals/day) dietary interventions on changes in body composition and health-related biomarkers.

Methods

A total of 41 overweight and sedentary female and male participants (38.0 ± 13 years, 90.1 ± 15 kg, 31.6 ± 6.6 kg/m2, 36.9 ± 7% fat) took part in a randomized, double-blind, and placebo-controlled study. The participants underwent baseline assessments and were then assigned to ingest 3 g/day of a placebo (PLA) or Momstamin 2′-F while initiating the exercise and weight-loss program. Follow-up tests were performed after 6 and 12 weeks. Data were analyzed using general linear model statistics with repeated measures and mean changes from baseline values with 95% confidence intervals (CIs).

Results

No group × time × sex interaction effects were observed, so group × time effects are reported. Participants in both groups saw comparable reductions in weight. However, those with 2′-FL demonstrated a significantly greater reduction in the percentage of body fat and less loss of the fat-free mass. Additionally, there was evidence that 2′-FL supplementation promoted more favorable changes in resting fat oxidation, peak aerobic capacity, IL-4, and platelet aggregation, with some minimal effects on the fermentation of short-chain fatty acids and monosaccharides in fecal samples. Moreover, participants’ perceptions regarding some aspects of the functional capacity and ratings of the quality of life were improved, and the supplementation protocol was well tolerated, although a small, but significant, decrease in BMC was observed.

Conclusions

The results support contentions that dietary supplementation of 2′-FL (3 g/d) can promote fat loss and improve exercise- and diet-related markers of health and fitness in overweight sedentary individuals initiating an exercise and weight-loss program. Further research is needed to explore the potential health benefits of 2′-FL supplementation in both healthy and elderly individuals (Registered clinical trial #NCT06547801).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrisaccharidesMilk, HumanBiomarkersWeight LossOverweightExerciseHumansFemaleMaleAdultDouble-Blind MethodMiddle AgedDietary SupplementsBody CompositionYoung Adult

Stichwörter der Autor:innen

functional capacityinflammationinsulin sensitivityprebioticquality of life

Substanzen

2'-fucosyllactoseTrisaccharidesBiomarkers

Autor:innen und Institutionen

  • Exercise & Sport Nutrition Lab, Department of Kinesiology and Sports Management, Texas A&M University, College Station, TX 77843, USA.
  • Center for Nutraceutical and Dietary Supplement Research, College of Health Sciences, University of Memphis, Memphis, TN 38152, USA.
  • Departments of Nutrition and Food Science and Technology, University of California Davis, Davis, CA 95616, USA.

ORCID-Profile: Drew E Gonzalez, Broderick L Dickerson, Megan Leonard, Victoria Jenkins, Marie van der Merwe, Carolyn M Slupsky, Ryan Sowinski, Richard B Kreider

Förderung

  • Advanced Protein Technologies Corp

Zitieren

APA

Ko, J., Yoo, C., Xing, D., Chun, J., Gonzalez, D. E., Dickerson, B. L., Leonard, M., Jenkins, V., van der Merwe, M., Slupsky, C. M., Sowinski, R., Rasmussen, C. J., & Kreider, R. B. (2024). Effects of Human Milk Oligosaccharide 2′-Fucosyllactose Ingestion on Weight Loss and Markers of Health. Nutrients. https://doi.org/10.3390/nu16193387

Vancouver

Ko J, Yoo C, Xing D, Chun J, Gonzalez DE, Dickerson BL, et al. Effects of Human Milk Oligosaccharide 2′-Fucosyllactose Ingestion on Weight Loss and Markers of Health. Nutrients. 2024. doi:10.3390/nu16193387

BibTeX
@article{Ko2024,
  author = {Ko, Joungbo and Yoo, Choongsung and Xing, Dante and Chun, Jisun and Gonzalez, Drew E and Dickerson, Broderick L and Leonard, Megan and Jenkins, Victoria and van der Merwe, Marie and Slupsky, Carolyn M and Sowinski, Ryan and Rasmussen, Christopher J and Kreider, Richard B},
  title = {Effects of Human Milk Oligosaccharide 2′-Fucosyllactose Ingestion on Weight Loss and Markers of Health},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16193387}
}
Kostenlos starten →